Companies / BOC Sciences / Simtuzumab
BOC Sciences

Simtuzumab | BOC Sciences

Simtuzumab is a humanized monoclonal antibody directed against LOXL2. Simtuzumab has been used in the research of primary sclerosing cholangitis (PSC).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.